AB 1139
9 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Browse all held record sources
Zoom to read. Drag to explore. Select a connection.
Every link on this map
The same connections as a table, with the reason each one is here.
| California Society of Dermatology & Dermatologic Surgery | Lobbied on it | California Society of Dermatology & Dermatologic Surgery named AB 1139 in 4 lobbying reports. | 4 reports |
| GSK | Lobbied on it | GSK named AB 1139 in 4 lobbying reports. | 4 reports |
| California Retailers Association | Lobbied on it | California Retailers Association named AB 1139 in 3 lobbying reports. | 3 reports |
| Genentech, Inc., A Member of the Roche Group | Lobbied on it | Genentech, Inc., A Member of the Roche Group named AB 1139 in 3 lobbying reports. | 3 reports |
| Teva Pharmaceuticals USA, Inc. | Lobbied on it | Teva Pharmaceuticals USA, Inc. named AB 1139 in 3 lobbying reports. | 3 reports |
| Amgen | Lobbied on it | Amgen named AB 1139 in 2 lobbying reports. | 2 reports |
| Biocom California | Lobbied on it | Biocom California named AB 1139 in 2 lobbying reports. | 2 reports |
| California Life Sciences | Lobbied on it | California Life Sciences named AB 1139 in 2 lobbying reports. | 2 reports |
| Prescriptions: biosimilar products. | Source records | AB 1139 has an explicit source reference to Prescriptions: biosimilar products.. | None |
In the news
Reporting about the selected subject. Articles are context and do not establish a connection on this map.
Loading coverage…

